Feb 18, 2020 / NTS GMT
Presentation
Feb 18, 2020 / NTS GMT
=====================
Corporate Participants
=====================
* Brent Andrew Cubis
Cochlear Limited - CFO
* Diggory William Howitt
Cochlear Limited - CEO, MD, President & Executive Director
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Marquee - Healthcare analyst
* Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst
* David A. Low
JP Morgan Chase & Co, Research Division - Research Analyst
* David Andrew Stanton
Jefferies LLC, Research Division - Equity Analyst
* David Bailey
Macquarie Research - Research Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* Hashan De Silva
CLSA Limited, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc, Research Division - Director & Head of Healthcare in Australia and New Zealand
* Lyanne Harrison
BofA Merrill
Cochlear Ltd
(STU:OC5)
€
170.24
-3.24 (-1.87%)
Market Cap: 11.29 Bil
Enterprise Value: 11.12 Bil
PE Ratio: 52.03
PB Ratio: 10.05
GF Score: 87/100 Half Year 2020 Cochlear Ltd Earnings Presentation Transcript
Feb 18, 2020 / NTS GMT
Release Date Price:
€139
(-4.14%)
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot